Dimitra Panteli

Dimitra Panteli

Auto-generated profile, based on publicly available information

Dimitra Panteli

Department of Health Care Management, Technische Universität Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in The Lancet Public Health
Verified
Journal Article
Open access
DPDimitra Panteli
Dimitra Panteli
KAKeyrellous Adib
Keyrellous Adib
SBStefan Buttigieg
Stefan Buttigieg
FGFrancisco Goiana-Da-Silva
Francisco Goiana-Da-Silva
KLKatharina Ladewig
Katharina Ladewig
MMMartin McKee
Martin McKee
Artificial intelligence (AI) can rapidly analyse large and complex datasets, extract tailored recommendations, support decision making, and improve the efficiency of many tasks that involve the processing of data, text, or images. As such, AI has the potential to revolutionise public health practice and research, but accompanying challenges need to be addressed. AI can be used to support public health surveillance, epidemiological research, communication, the allocation of resources, and other forms of decision making. It can also improve productivity in daily public health work. Core challenges to its widespread adoption span equity, accountability, data privacy, the need for robust digital infrastructures, and workforce skills. Policy makers must acknowledge that robust regulatory frameworks covering the lifecycle of relevant technologies are needed, alongside sustained investment in infrastructure and workforce development. Public health institutions can play a key part in advancing the meaningful use of AI in public health by ensuring their staff are up to date regarding existing regulatory provisions and ethical principles for the development and use of AI technologies, thinking about how to prioritise equity in AI design and implementation, investing in systems that can securely process the large volumes of data needed for AI applications and in data governance and cybersecurity, promoting the ethical use of AI through clear guidelines that align with human rights and the public good, and considering AI's environmental impact.

1 December 2021 in Health Policy
Verified
Journal Article
Closed access
EBElke Berger
Elke Berger
JWJuliane Winkelmann
Juliane Winkelmann
HEHelene Eckhardt
Helene Eckhardt
UNUlrike Nimptsch
Ulrike Nimptsch
DPDimitra Panteli
Dimitra Panteli
RBReinhard Busse
Reinhard Busse

9 March 2022 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
JWJuliane Winkelmann
Juliane Winkelmann
JRJesús Gómez Rossi
Jesús Gómez Rossi
Falk SchwendickeFalk Schwendicke
Falk Schwendicke
ADAntoniya Dimova
Antoniya Dimova
EAElka Atanasova
Elka Atanasova
DPDimitra Panteli
Dimitra Panteli
Background: Oral health, coupled with rising awareness on the impact that limited dental care coverage has on oral health and general health and well-being, has received increased attention over the past few years. The purpose of the study was to compare the statutory coverage and access to dental care for adult services in 11 European countries using a vignette approach. Methods: We used three patient vignettes to highlight the differences of the dimensions of coverage and access to dental care (coverage, cost-sharing and accessibility). The three vignettes describe typical care pathways for patients with the most common oral health conditions (caries, periodontal disease, edentulism). The vignettes were completed by health services researchers knowledgeable on dental care, dentists, or teams consisting of a health systems expert working together with dental specialists. Results: Completed vignettes were received from 11 countries: Bulgaria, Estonia, France, Germany, Republic of Ireland (Ireland), Lithuania, the Netherlands, Poland, Portugal, Slovakia and Sweden. While emergency dental care, tooth extraction and restorative care for acute pain due to carious lesions are covered in most responding countries, root canal treatment, periodontal care and prosthetic restoration often require cost-sharing or are entirely excluded from the benefit basket. Regular dental visits are also limited to one visit per year in many countries. Beyond financial barriers due to out-of-pocket payments, patients may experience very different physical barriers to accessing dental care. The limited availability of contracted dentists (especially in rural areas) and the unequal distribution and lack of specialised dentists are major access barriers to public dental care. Conclusions: According to the results, statutory coverage of dental care varies across European countries, while access barriers are largely similar. Many dental services require substantial cost-sharing in most countries, leading to high out-of-pocket spending. Socioeconomic status is thus a main determinant for access to dental care, but other factors such as geography, age and comorbidities can also inhibit access and affect outcomes. Moreover, coverage in most oral health systems is targeted at treatment and less at preventative oral health care.

12 September 2024 in Health Policy
Verified
Journal Article
Open access
YLYulia Litvinova
Yulia Litvinova
SMSherry Merkur
Sherry Merkur
SASara Allin
Sara Allin
EAEster Angulo-Pueyo
Ester Angulo-Pueyo
DBDaiga Behmane
Daiga Behmane
DPDimitra Panteli
Dimitra Panteli
Chimeric antigen receptor T-cell therapies (CAR-T therapies) are a type of advanced therapy medicinal product (ATMP) that belong to a new generation of personalised cancer immunotherapies. This paper compares the approval, availability and financing of CAR-T cell therapies in ten countries. It also examines the implementation of this type of ATMP within the health care system, describing the organizational elements of CAR-T therapy delivery and the challenges of ensuring equitable access to all those in need, taking a more systems-oriented view. It finds that the availability of CAR-T therapies varies across countries, reflecting the heterogeneity in the organization and financing of specialised care, particularly oncology care. Countries have been cautious in designing reimbursement models for CAR-T cell therapies, establishing limited managed entry arrangements under public payers, either based on outcomes or as an evidence development scheme to allow for the study of real-world therapeutic efficacy. The delivery model of CAR-T therapies is concentrated around existing experienced cancer centres and highlights the need for high networking and referral capacity. Some countries have transparent and systematic eligibility criteria to help ensure more equitable access to therapies. Overall, as with other pharmaceuticals, there is limited transparency in pricing, eligibility criteria and budgeting decisions in this therapeutic area.

28 November 2024 in JMIR Mental Health
Verified
Journal Article
Open access
Pauline Sarah MünchenbergPauline Sarah Münchenberg
Pauline Sarah Münchenberg
DYDinara Yessimova
Dinara Yessimova
DPDimitra Panteli
Dimitra Panteli
TKTobias Kurth
Tobias Kurth
Background: First-episode psychosis (FEP) imposes a substantial burden not only on the individual affected but also on their families. Given that FEP usually occurs during adolescence, families overtake a big part of informal care. Early family interventions, especially psychoeducation, are crucial for informal family caregivers to best support the recovery of their loved one with FEP and to reduce the risk of a psychotic relapse as much as possible, but also to avoid chronic stress within the family due to the burden of care. Digital health interventions offer the possibility to access help quicker, use less resources, and improve informal family caregiver outcomes, for example, by reducing stress and improving caregiver quality of life. Objective: This study aimed to systematically identify studies on digital health interventions for informal family caregivers of people with FEP and to describe and synthesize the available literature on user experience, as well as the effectiveness of such digital applications on the clinical outcomes, consisting of (1) perceived caregiver stress, (2) expressed emotion, and (3) parental self-efficacy. Methods: A systematic search was carried out across 4 electronic databases. In addition, reference lists of relevant studies were hand-searched. This review aimed to include only primary studies on informal family caregivers, who had to care for a person with FEP between 15 years and 40 years of age and a diagnosis of FEP with onset of observed symptoms within the past 5 years. All types of digital interventions were included. This systematic review is aligned with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) 2020 guidelines. Results: The search identified 7 studies that reported on user experience or effectiveness of digital health interventions on perceived caregiver stress, expressed emotion, and parental self-efficacy, including 377 informal family FEP caregivers across trials. Digital health interventions–web-based, videoconferences, and mHealth–were well accepted and perceived as relevant, easy to use, and helpful by informal family FEP caregivers. Psychoeducational content was rated as the most important across studies. Perceived caregiver stress, expressed emotion, and parental self-efficacy improved in all studies that reported on these clinical outcomes. Conclusions: The results of this review suggest that digital health interventions aimed at informal family caregivers of individuals with FEP can improve relevant clinical outcomes, with participants reporting a positive user experience. However, for some interventions reviewed, specialized in-person family care outperformed the digital intervention and partially led to better results in perceived caregiver stress and parental self-efficacy. Therefore, while digital interventions present a promising approach to alleviate the burden of care and improve informal family FEP caregiver outcomes, more studies with well-powered experimental designs are needed to further investigate the effectiveness of such applications in this population. Trial Registration: PROSPERO CRD42024536715; https://tinyurl.com/bdd3u7v9

10 July 2021 in Human Resources for Health
Verified
Journal Article
Open access
PDF file
DPDimitra Panteli
Dimitra Panteli
CMClaudia B. Maier
Claudia B. Maier
In the European free movement zone, various mechanisms aim to harmonize how the competence of physicians and nurses is developed and maintained to facilitate the cross-country movement of professionals. This commentary addresses these mechanisms and discusses their implications during the COVID-19 pandemic, drawing lessons for future policy. It argues that EU-wide regulatory mechanisms should be reviewed to ensure that they provide an adequate foundation for determining competence and enabling health workforce flexibility during health system shocks. Currently, EU regulation focuses on the automatic recognition of the primary education of physicians and nurses. New, flexible mechanisms should be developed for specializations, such as intensive or emergency care. Documenting new skills, such as the ones acquired during rapid training in the pandemic, in a manner that is comparable across countries should be explored, both for usual practice and in light of outbreak preparedness. Initiatives to strengthen continuing education and professional development should be supported further. Funding under the EU4Health programme should be dedicated to this endeavour, along with revisiting the scope of necessary skills following the experience of COVID-19. Mechanisms for cross-country sharing of information on violations of good practice standards should be maintained and strengthened to enable agile reactions when the need for professional mobility becomes urgent.